Platelets are Hyperactivated but Show Reduced Glycoprotein VI Reactivity in COVID-19 Patients
Valentine Léopold(Inserm), Tom van der Poll(Amsterdam Neuroscience), Anno Saris(Leiden University Medical Center), Tom D. Y. Reijnders(Amsterdam University Medical Centers), Alex R. Schuurman(Amsterdam Neuroscience), Christine C. A. van Linge(Amsterdam University Medical Centers), W. Joost Wiersinga(Amsterdam Neuroscience), Justin de Brabander, Osoul Chouchane(Amsterdam Neuroscience), Renée A. Douma(Amsterdam UMC Location University of Amsterdam), Rienk Nieuwland(Dutch Cancer Society), Cornelis van ′t Veer(Radboud University Nijmegen), Э. В. Переверзева
Cited by 37
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Sepsis: a roadmap for future research
|The Lancet Infectious Diseases|2015|1k